Fröhlich Samanta Etges, Mengue Sotero Serrate
Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, 90610-000, Brazil.
Cien Saude Colet. 2011 Apr;16(4):2289-96. doi: 10.1590/s1413-81232011000400028.
The scope of this article is to analyze the drug prescription quality indicators proposed by the World Health Organization in 1993 and suggest new indicators attuned to the new profile of illness of the population. For this purpose, a cross-sectional study was conducted by means of personal interviews and prescription analysis among 320 patients who were attended at Strategic Family Health Units located in a Brazilian municipality in the state of Rio Grande do Sul. The users were recruited by the consecutive nonprobabilistic sampling method. In accordance with the drug prescription quality indicators of the World Health Organization, the prescriptions can be considered adequate. However, analysis of those indicators shows that they may currently be inappropriate. Therefore, new indicators were created. Using the new, easily quantifiable and straightforward indicators proposed, it was possible to detect the problems in a drug prescription with a view to taking corrective action.
本文的范围是分析世界卫生组织于1993年提出的药物处方质量指标，并提出符合人群新疾病特征的新指标。为此，通过个人访谈和处方分析，对巴西南里奥格兰德州一个市的战略家庭健康单位接待的320名患者进行了横断面研究。采用连续非概率抽样方法招募使用者。根据世界卫生组织的药物处方质量指标，这些处方可被视为适当。然而，对这些指标的分析表明，它们目前可能并不合适。因此，创建了新的指标。使用所提出的新的、易于量化且直接的指标，能够检测药物处方中的问题，以便采取纠正措施。
